PEPTIDEREPORT

Primary-source enforcement database

Regulatory Watch

Agency actions are stored once and automatically connected to every affected company and compound profile. A warning letter is a public regulatory record, not a final adjudication or a current-status conclusion.

1 actions tracked1 companies linked2 compounds linked
FDA Warning letter

Gram Peptides — FDA Warning Letter 721806

The FDA stated that products offered by Gram Peptides were unapproved new drugs and that website content evidenced intended human-drug use despite research-use-only labeling.

Companies: Gram Peptides

Compounds: Retatrutide, Tirzepatide

Read the primary-source record